Corporate News | Services & Solutions | Software | Computing Products | Telecommunications | Microelectronics |
Services & Solutions
- 13 December 2005 San Francisco, CA
- The BioSciences Group of Fujitsu Announces CELLINJECTOR Evaluation Project with Whitehead Institute for High-Throughput Cell-Based
Research
San Francisco, CA, December 13, 2005 – At the American Society for Cell Biology (ASCB) Annual Meeting today, the BioSciences Group of Fujitsu Computer Systems announced a new evaluation project with Whitehead Institute for Biomedical Research, focusing on high-throughput cell-based research.
- 29 November 2005 Edison, NJ
- Fujitsu’s Industry-Leading Macroscope® to Be Fueled by Microsoft Visual Studio 2005 Team System
Edison, NJ, November 29, 2005 – Fujitsu Consulting today announced its decision to utilize the power and flexibility of Microsoft Visual Studio 2005 Team System to enhance its industry-leading Macroscope®, the company’s comprehensive suite of business and IT methodologies. Macroscope for Microsoft Visual Studio 2005 Team System will use Visual Studio 2005 Team System to enact Macroscope through software tools, add-ins and templates that enhance the project delivery capabilities of Macroscope.
- 10 August 2005 Westwood, MA
- The BioSciences Group of Fujitsu Introduces CELLINJECTOR™ Automated Microinjection System
Westwood, MA, August 10, 2005 – The BioSciences Group of Fujitsu Computer Systems today announced that it has developed an automated microinjection system called CELLINJECTOR, to enable very large-scale direct injection of agents through cell membranes for biochemical research.
- 11 July 2005 Westwood, Massachusetts
- The BioSciences Group of Fujitsu Unveils New in silico Technique for Enhanced ADME/Tox Predictions
Westwood, Massachusetts, July 11, 2005 – The BioSciences Group of Fujitsu Computer Systems today unveiled a new technique for generating enhanced predictions for ADME/Tox research, consisting of a unique docking-based approach combined with off-the-shelf and purpose-built technologies, to develop viable and effective predictive models. The new approach was developed with a commercial collaborator focusing on drug-resistant infectious diseases and cancer.
- 18 May 2005 Bio-IT World Expo - Boston, Massachusetts
- The BioSciences Group of Fujitsu Offers 'High Throughput Docking' to Overcome Challenges of High Throughput Screening
Bio-IT World Expo - Boston, Massachusetts, May 18, 2005 – At Bio-IT World Expo in Boston, The BioSciences Group of Fujitsu Computer Systems demonstrated its offerings in "High Throughput Docking," (HT Docking) as a means to make High Throughput Screening (HTS) more productive and effective in drug discovery.
- 2 May 2005 Edison, NJ and Minneapolis, MN
- Fujitsu Accelerates North American Growth with Acquisition of BORN
Edison, NJ and Minneapolis, MN, May 2, 2005 – Fujitsu Consulting, part of Fujitsu's global software and services business, and BORN, a leading business and technology consulting firm headquartered in Minneapolis, Minn., today announced that they have signed a definitive agreement under which Fujitsu Consulting will acquire the capital stock of BORN. The agreement is subject to closing conditions and is expected to be completed within 30 to 45 days. Additional terms were not disclosed.
- 14 April 2005 Sunnyvale, CA
- Fujitsu Transfers BioSciences Group to Provide Enhanced Service and Support to Life Sciences Market
Sunnyvale, CA, April 14, 2005 – "We are very pleased to have The BioSciences Group join Fujitsu Computer Systems," said Toshio Morohoshi, President & CEO, Fujitsu Computer Systems Corporation. "We see this transfer as the ideal integration of expertise and services. The BioSciences Group gains expertise in enterprise-scale solutions, and provides life sciences-specific technologies and services in order to introduce Fujitsu offerings in the North American life sciences market."
- 14 April 2005 Sunnyvale, CA
- Fujitsu Transfers BioSciences Group to Provide Enhanced Service and Support to Life Sciences Market
Sunnyvale, CA, April 14, 2005 – Fujitsu Computer Systems Corporation, a wholly-owned subsidiary of Fujitsu Limited, announced the transfer of the BioSciences Group, a worldwide leader in providing innovative and reliable solutions to experimental scientists, from Fujitsu America, Inc. to Fujitsu Computer Systems Corporation.
- 23 March 2005 Montreal, Que.
- Fujitsu Consulting Invests in MOXXI Medical to Accelerate Deployment of Next-Generation Prescription Management System
Montreal, Que., March 23, 2005 – Fujitsu Consulting today announced a strategic investment and alliance agreement with Montreal-based MOXXI Medical Inc., a leader in next-generation prescription drug management delivery systems. The investment is aligned to a global strategy by Fujitsu to focus on the health services market.
- 16 March 2005 Edison, NJ
- Fujitsu Consulting Expands BPO Capability with Cendera
Edison, NJ, March 16, 2005 – Fujitsu Consulting today announced that it has expanded its telecommunications outsourcing capabilities through the addition of Dallas, Texas-based Cendera Technologies, a company dedicated to delivery of professional services and custom software solutions. Under the terms of the agreement Fujitsu Consulting has acquired assets of Cendera, along with its veteran staff of telecommunications software developers and operational support systems (OSS) specialists. The deal significantly enhances Fujitsu’s existing business process outsourcing (BPO) capabilities, providing the firm with even greater expertise in the telecommunications industry.
- 22 February 2005 Westwood, MA
- Fujitsu America BioSciences Group Announces Agreement with NeurAxon for BioMedCAChe™ Automated Docking Software with
ActiveSite™ Module
Westwood, MA, February 22, 2005 – The BioSciences Group of Fujitsu America, Inc., a worldwide leader in providing innovative and reliable solutions to experimental scientists, today announced a licensing agreement for its BioMedCAChe suite of automated docking and molecular modeling software with NeurAxon, Inc., a Canadian company specializing in drug development for pain and central nervous system (CNS) disorders. The deal includes provision of the BioSciences Group’s ActiveSite module for designing effective small molecule inhibitors of protein targets.
- 17 January 2005 Cambridge, MA
- Fujitsu Teams up with Vertical Communications to Resell and Provide Systems Integration Services for Vertical's Integrated
Communications Platform
Cambridge, MA, January 17, 2005 – Vertical Communications, Inc. (Vertical) (ASFTE.OB), a leading provider of next-generation, IP-based phone systems for small, large and distributed businesses, today announced that Fujitsu Transaction Solutions (Fujitsu) has agreed to resell and re-market Vertical's integrated communications solutions to customers in retail and other vertical markets. With Fujitsu's knowledge of retailers' communications needs, Fujitsu will deploy complete, IP-based phone systems that encompass planning, provisioning and support using the Vertical Retail Suite - an integrated IP-PBX and voice application solution tailored to the unique requirements of retailers and their stores.
- 11 January 2005 Westwood, MA
- Fujitsu America BioSciences Group Announces Global Licensing Deal with GPC Biotech AG for BioMedCAChe™ Automated Docking
Software
Westwood, MA, January 11, 2005 – The BioSciences Group of Fujitsu America, Inc., a worldwide leader in providing innovative and reliable solutions to experimental scientists, today announced a global licensing agreement with GPC Biotech AG, a global cancer drug discovery and development company, for Fujitsu's BioMedCAChe suite of automated docking and molecular modeling software. GPC Biotech will implement BioMedCAChe in its Waltham, Massachusetts and Martinsried/Munich, Germany sites.
